Unique ID issued by UMIN | UMIN000053480 |
---|---|
Receipt number | R000061011 |
Scientific Title | Evaluation of the prototype device for neutral fat monitoring by high-fat meal tolerance test |
Date of disclosure of the study information | 2024/02/02 |
Last modified on | 2024/07/30 09:39:18 |
Evaluation of the prototype device for neutral fat monitoring by high-fat meal tolerance test
Evaluation of the prototype device for neutral fat monitoring by high-fat meal tolerance test
Evaluation of the prototype device for neutral fat monitoring by high-fat meal tolerance test
Evaluation of the prototype device for neutral fat monitoring by high-fat meal tolerance test
Japan |
Not applicable
Adult |
Others
NO
To confirm accuracy and characteristics of the neutral fat monitoring device, which is under development, by comparing the data from gold-standard
Others
Correlation between the data from prototype device and the data from venous blood sample on neutral fat levels
Correlation between the prototype device and the following neutral fat levels
1)Blood glucose level by venous blood collection.
2)Blood glucose level by continuous glucose monitoring.
Interventional
Parallel
Non-randomized
Open -no one is blinded
Placebo
2
Prevention
Food |
Oral 40g fat(venous blood collection)
Oral 40g fat(device)
20 | years-old | <= |
Not applicable |
Male and Female
1)Males and females aged 20 years or older at the time of informed consent.
2)Subjects who can make self-judgment and voluntarily gave written informed consent.
3)Subjects whose fasting neutral fat levels are 150mg/dL or more and less than 300mg/dL at a health checkup within the past year.
1)Subjects who are on treatment for a serious illness.
2)Subjects who have been diagnosed with dyslipidemia, nephrotic syndrome, pancreatitis, hypothyroidism, or diabetes mellitus and who are on treatment or medication.
3)Subjects with food allergy. Subjects who are at risk of developing allergies related to the 40g high-fat meal tolerance test.
4)Subjects who regularly use licensed drugs or quasi-drugs that may affect the study.
5)Subjects who are currently on treatment at a medical institution for a disease that may affect the study.
6)Subjects who are participating in a clinical trial or have participated in another clinical trial within 1 month before the date of consent for this study.
7)Subjects who are pregnant and those who are breastfeeding.
8)Subjects who plan to participate in another clinical trial during this study period.
9)Subjects who have difficulty in wearing the prototype device.
10)Subjects who judged as unsuitable for this study by the principal investigator for any reasons.
10
1st name | Toshio |
Middle name | |
Last name | Miyata |
DEN Medical Corporation MIH Clinic Yoyogi.
Chairman of the board
151-0051
2F Value HR Building, 5-21-14 Sendagaya, Shibuya-ku, Tokyo
03-6276-5385
info@mih-clinic.com
1st name | Masako |
Middle name | |
Last name | Mizuuchi |
APO PLUS STATION CO., LTD
CRO Business division
103-0027
Front Place Nihonbashi,2-14-1 Nihonbashi, Chuo-ku, Tokyo
03-6386-8809
food-contact@apoplus.co.jp
APO PLUS STATION CO., LTD.
TANITA Corporation
Profit organization
Ethics Review Committee, ITO Yoyogi Mental Clinic
4-26-11 Sendagaya, Shibuya-ku, Tokyo
03-6804-2227
cns_jimu@triad-j.co.jp
NO
医療法人社団DENみいクリニック代々木
2024 | Year | 02 | Month | 02 | Day |
Unpublished
10
Completed
2024 | Year | 01 | Month | 15 | Day |
2024 | Year | 01 | Month | 15 | Day |
2024 | Year | 02 | Month | 06 | Day |
2024 | Year | 02 | Month | 29 | Day |
2024 | Year | 01 | Month | 30 | Day |
2024 | Year | 07 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061011